publication date: Oct. 14, 2016

In Brief Adrian Lee named director of the Institute for Precision Medicine

ADRIAN LEE was named director of the Institute for Precision Medicine, a joint effort by UPMC and the University of Pittsburgh.

A breast cancer expert, Lee is a professor in the Department of Pharmacology and Chemical Biology at Pitt, and director of the Women’s Cancer Research Center, University of Pittsburgh Cancer Institute.

In addition to studying the hormonal regulation of breast cancer, Lee is part of the team working to implement the technology infrastructure needed for precision medicine. He succeeds Associate Vice Chancellor Jeremy Berg, who will remain as a senior adviser to the IPM, founded in 2013 and formerly known as the Institute for Personalized Medicine.

Under Lee, the IPM will build on precision medicine efforts underway at Pitt and UPMC, including implementation of new clinical trials and procurement of significant National Institutes of Health and state funding.

In July, the NIH announced an award to Pitt that could top $46 million over five years to build the infrastructure and partnerships needed to launch the Cohort Program of President Obama’s Precision Medicine Initiative—a landmark effort to engage more than 1 million U.S. participants in providing clinical, genomic and other data that could lead to new ways … Continue reading 42-38 Adrian Lee named director of the Institute for Precision Medicine

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.